Clinical Trial Update: RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine) [Phase 2]

View source ↗

Summary

This update covers the Platform Protocol Appendix B evaluating ivabradine for autonomic symptoms in Long COVID (RECOVER-AUTONOMIC) in Phase 2. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Kanecia Obie Zimmerman | Conditions: Long COVID, Long Covid19 | Phase 2 | Status: COMPLETED